Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 555.43 billion as of December 5, 2025. Its market cap has increased by 32.48% in one year.

Market Cap

555.43B

Enterprise Value

540.76B

Revenue

159.97B

Ranking

n/a

PE Ratio

55.00

Stock Price

1,965.75

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 555.43B, an increase of 48,227.34%. That is a compound annual growth rate of 28.68%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	555.43B	22.32%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	20.78T
HDFC Bank	15.34T
Bharti Airtel	12.63T
Tata Consultancy Services	11.68T
ICICI Bank	9.91T
State Bank of India	8.97T
Infosys	6.62T
Bajaj Finance	6.39T

Market Cap Rankings